Journal article icon

Journal article

Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study

Abstract:

Background Typhoid fever is a major cause of morbidity and mortality in low-income and middle-income countries. In 2017, WHO recommended the programmatic use of typhoid Vi-conjugate vaccine (TCV) in endemic settings, and Gavi, The Vaccine Alliance, has pledged support for vaccine introduction in these countries. Country-level health economic evaluations are now needed to inform decision-making.

Methods In this modelling study, we compared four strat...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1016/s1473-3099(18)30804-1

Authors


Expand authors...
Publisher:
Elsevier Publisher's website
Journal:
Lancet Infectious Diseases Journal website
Volume:
19
Issue:
7
Pages:
728-739
Publication date:
2019-05-23
Acceptance date:
2018-12-14
DOI:
EISSN:
1474-4457
ISSN:
1473-3099
Pmid:
31130329
Source identifiers:
1007368
Language:
English
Pubs id:
pubs:1007368
UUID:
uuid:4dc14378-c3b2-40e9-a490-9ef805099596
Local pid:
pubs:1007368
Deposit date:
2019-06-06

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP